These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6235193

  • 21. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
    Stenina MA, Potapova AA, Biriukov AV, Skripnik AIu, Cheredeev AH.
    Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
    [Abstract] [Full Text] [Related]

  • 22. [Disturbance of immunogenesis in patients with systemic lupus erythematosus].
    Adamian NV, Solov'ev SK, Gambarov SS, Alekseev LP.
    Ter Arkh; 1989 Aug; 61(5):43-5. PubMed ID: 2528836
    [Abstract] [Full Text] [Related]

  • 23. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM, Birch RE, Polmar SH.
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD, Krakauer RA, Frank SA, Calabrese LH.
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [Abstract] [Full Text] [Related]

  • 25. Con A suppressor cell assay: a further characterization.
    Meroni PL, Balestrieri G, Barcellini W, DeBartolo G, Fenini G, Tincani A, Zanussi C.
    J Clin Lab Immunol; 1983 Mar; 10(3):159-63. PubMed ID: 6221109
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R, Patel DR, Najera D.
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [Abstract] [Full Text] [Related]

  • 28. Effects of levamisole on in vitro suppressosr cell function in normal humans and patients with systemic lupus erythematosus.
    Rabson A, Blank S, Lomnitzer R.
    Immunopharmacology; 1980 Apr; 2(2):103-8. PubMed ID: 6449486
    [Abstract] [Full Text] [Related]

  • 29. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM, Fauci AS.
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [Abstract] [Full Text] [Related]

  • 30. Familial alterations of immunoregulation in systemic lupus erythematosus.
    Spencer-Green G, Adams LE, Hurtubise P, Kravatz G, Hess EV.
    J Rheumatol; 1985 Jun; 12(3):498-503. PubMed ID: 2931520
    [Abstract] [Full Text] [Related]

  • 31. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A, Gonzalez-Cabello R, Gergely P.
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [Abstract] [Full Text] [Related]

  • 32. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T, Tanaka S, Steinberg AD, Matsuyama T, Daley J, Schlossman SF, Morimoto C.
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [Abstract] [Full Text] [Related]

  • 33. Normal suppressor-cell activity in systemic lupus erythematosus. A study on 26 cases.
    Gattringer C, Huber H, Michlmayr G, Braunsteiner H.
    Immunobiology; 1982 Oct; 163(1):48-52. PubMed ID: 6217149
    [Abstract] [Full Text] [Related]

  • 34. [Analysis of suppressor T cell functions in SLE].
    Sakane T.
    Nihon Rinsho; 1983 Oct; 41(4):766-73. PubMed ID: 6224950
    [No Abstract] [Full Text] [Related]

  • 35. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
    Katagiri T.
    Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
    [Abstract] [Full Text] [Related]

  • 36. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T, Steinberg AD, Reeves JP, Green I.
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [Abstract] [Full Text] [Related]

  • 37. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
    Twomey JJ, Laughter AH, Steinberg AD.
    J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of the detection of circulating immune complexes in lupus nephritis.
    Coppo R, Bosticardo GM, Basolo B, Messina M, Mazzucco G, Stratta P, Quarello F, Alloatti S, Piccoli G.
    Nephron; 1982 Sep; 32(4):320-8. PubMed ID: 6984741
    [Abstract] [Full Text] [Related]

  • 39. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q, Su H, Cui J, Wang B.
    Immunol Invest; 2012 Sep; 41(1):15-27. PubMed ID: 21563925
    [Abstract] [Full Text] [Related]

  • 40. CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients.
    Żabińska M, Krajewska M, Kościelska-Kasprzak K, Jakuszko K, Bartoszek D, Myszka M, Klinger M.
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):399-407. PubMed ID: 27156107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.